查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1941819

美國耐用醫療設備市場規模、佔有率和趨勢分析報告：按產品、最終用途和細分市場預測（2026-2033 年）

U.S. Durable Medical Equipment Market Size, Share & Trends Analysis Report By Product, By End Use, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 300 Pages | 商品交期: 2-10個工作天內

價格

美國耐用醫療設備市場概述

據估計，2025年美國耐用醫療設備市場價值為706.6億美元，預計到2033年將達到1,087.3億美元。

預計2026年至2033年，該市場將以5.51%的複合年成長率成長。癌症、神經系統疾病、糖尿病和心臟病等慢性疾病的發生率逐年上升。根據美國疾病管制與預防中心（CDC）2024年5月發布的數據，糖尿病、心臟病和癌症等慢性疾病是美國殘疾和致死的主要原因。患有癌症等慢性疾病的患者人數不斷增加，而且由於慢性疾病患者可能存在行動不便的問題，因此對耐用醫療設備的需求預計將會成長。

根據Lifeway Mobility於2023年9月發表的報導，約有25%至35%的癌症患者會出現行走困難、平衡失調和四肢麻木等問題。因此，隨著癌症發生率的上升，美國對助行器、輪椅和其他行動輔助設備等耐用型醫療設備的需求預計將會成長。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：耐用醫療設備市場的變數、趨勢與範圍

  • 市場譜系展望
    • 相關市場展望
  • 監管情景
  • 救贖方案
  • 市場動態
  • 耐用醫療設備市場分析工具
    • 產業分析：波特五力模型
    • PESTEL 分析
    • 新冠疫情影響分析

第4章：耐用醫療設備市場：產品具體估算與趨勢分析

  • 耐用醫療設備市場：產品波動分析及市場佔有率（2025 年及 2033 年）
  • 個人行動裝置
    • 輪椅市場
    • Scooter市場
    • 沃克和羅勒市場
    • 起重機和拐杖市場
    • 開門器市場
    • 其他設備市場
  • 浴室安全裝置和醫療家具
    • 廁所和廁所市場
    • 床墊和寢具市場
  • 行政和治療設備
    • 血糖值儀市場
    • 持續被動運動（CPM）市場
    • 輸液幫浦市場
    • 霧化器市場
    • 輸液幫浦市場
    • 氧氣供應設備市場
    • 持續性陽壓呼吸器（CPAP）市場
    • 吸泵市場
    • 牽引設備市場
    • 其他市場

第5章：耐用醫療設備市場：依最終用途分類的估算與趨勢分析

  • 耐用醫療設備市場：波動分析及依最終用途分類的市場佔有率（2025 年及 2033 年）
  • 醫院
  • 專科診所
  • 門診手術中心
  • 診斷中心
  • 居家醫療
  • 其他

第6章 競爭情勢

  • 參與企業的分類
  • 主要企業簡介
    • Invacare Corporation
    • Sunrise Medical
    • Arjo
    • Medline Industries, Inc.
    • GE HealthCare
    • GF Healthcare Products, Inc.
    • Carex Health Brands, Inc.
    • Cardinal Health
    • Drive DeVilbiss Healthcare
    • NOVA Medical Products
    • Kaye Products, Inc.
    • Karman Healthcare, Inc.
    • Numotion
    • Pride Mobility Products Corporation
    • Inogen, Inc.
    • CAIRE, Inc.
    • Portable Oxygen Solutions
    • Rhythm Healthcare, LLC
    • MedaCure Inc.
    • Compass Health Brands
    • Thermo Fisher Scientific, Inc.
    • Abbott
    • F. Hoffmann-La Roche Ltd.
    • Medtronic
    • Ascensia Diabetes Care Holdings AG
    • Byram Healthcare Centers, Inc.
    • Novo Nordisk
    • Insulet Corporation
    • Baxter
    • B. Braun SE
    • Micrel Medical Devices SA
    • Boston Scientific Corporation
    • Tandem Diabetes Care, Inc.
    • BD
    • Moog, Inc.
    • IRadimed Corporation
    • Koninklijke Philips NV
    • Siemens Medical Solutions USA, Inc.
    • Essity
    • Coloplast Corporation
    • Paul Hartmann AG
    • Hollister Incorporated
    • Convatec Group PLC
    • Enovis Corporation
    • Zynex, Inc.
    • ZOLL Medical Corporation
    • Ossur
    • Breg, Inc.
    • Bauerfeind USA, Inc.
    • Biotronik
    • AliMed
  • 地圖分析/企業市場分析
  • 企業市場占有率預測分析（2025 年）
  • 其他主要市場參與者名單
Product Code: GVR-1-68038-926-5

U.S. Durable Medical Equipment Market Summary

The U.S. durable medical equipmentmarket size was estimated at USD 70.66 billion in 2025 and is projected to reach USD 108.73 billion by 2033, growing at a CAGR of 5.51% from 2026 to 2033. The prevalence of chronic diseases, such as cancer, neurological conditions, diabetes, and heart disorders, is increasing annually. According to the data published by the CDC in May 2024, chronic diseases such as diabetes, heart disease, & cancer are the leading causes of disability and death in the U.S. The increasing number of individuals suffering from chronic diseases such as cancer is anticipated to boost the demand for durable medical equipment as patients suffering from chronic conditions can experience mobility issues.

According to an article published by Lifeway Mobility in September 2023, around 25%-35% of cancer patients experience issues with walking, balance, and limb numbness. Hence, the growing cancer prevalence is anticipated to boost the demand for durable medical equipment, such as walkers, wheelchairs, and other mobility solutions in the U.S.

U.S. Durable Medical Equipment Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. durable medical equipment market report based on product, and end use.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Personal Mobility Devices
    • Wheelchairs
    • Electric Wheelchairs
    • Manual Wheelchairs
    • Scooters
    • Walker and Rollators
    • Cranes and Crutches
    • Door Openers
    • Other Devices
  • Bathroom Safety Devices and Medical Furniture
    • Commodes and Toilets
    • Mattress & Bedding Devices
  • Monitoring and Therapeutic Devices
    • Blood Glucose Monitors
    • Continuous Passive Motion (CPM)
    • Infusion Pumps
    • Nebulizers
    • Oxygen equipment
    • Continuous Positive Airway Pressure (CPAP)
    • Suction Pumps
    • Traction Equipment
    • Others
    • Insulin Pumps
    • Ostomy Bags & Accessories
    • Wound Care Products
    • Cardiology Devices
    • Vital Signs Monitor
    • Respiratory Supplies
    • Urinary Supplies
    • Diabetic Supplies
    • Incontinence Products
    • Orthopedic Braces & Support
    • Muscle Stimulators
    • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Home Healthcare
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. DME Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Regulatory Scenario
  • 3.3. Reimbursement Scenario
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
      • 3.4.1.1. Increasing prevalence of chronic diseases
      • 3.4.1.2. Rising geriatric population
      • 3.4.1.3. Technological advancements and growing AI integration
      • 3.4.1.4. Growing number of sports & road accidents coupled with the increasing number of injuries
      • 3.4.1.5. Favorable government initiatives
    • 3.4.2. Market Restraint Analysis
      • 3.4.2.1. High costs associated with durable medical equipment
      • 3.4.2.2. Lack of skilled professionals to handle this equipment
    • 3.4.3. Market Opportunity Analysis
      • 3.4.3.1. Growing demand for home healthcare services
      • 3.4.3.2. Improving reimbursement for durable medical equipment
      • 3.4.3.3. Rising production of medical equipment
      • 3.4.3.4. Growing accessibility and availability of medical equipment
      • 3.4.3.5. Increasing investments in medical
    • 3.4.4. Market Challenge Analysis
      • 3.4.4.1. Product recall
      • 3.4.4.2. Growing accessibility and availability of medical equipment
  • 3.5. DME Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Bargaining power of suppliers
      • 3.5.1.2. Bargaining power of buyers
      • 3.5.1.3. Threat of substitutes
      • 3.5.1.4. Threat of new entrants
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political & Legal Landscape
      • 3.5.2.2. Economic and Social Landscape
      • 3.5.2.3. Technological landscape
    • 3.5.3. COVID-19 Impact Analysis
      • 3.5.3.1. Disrupted DME
      • 3.5.3.2. Obstacles in DME

Chapter 4. DME Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. DME Market: Product Movement Analysis & Market Share, 2025 & 2033
  • 4.3. Personal Mobility Devices
    • 4.3.1. Personal Mobility Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. Wheelchairs Market
      • 4.3.2.1 Wheelchairs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.2 Electric Wheelchairs Market
        • 4.3.2.2.1 Electric Wheelchairs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.3 Manual Wheelchairs Market
        • 4.3.2.3.1 Manual Wheelchairs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3. Scooters Market
      • 4.3.3.1 Scooters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.4. Walker and Rollators Market
      • 4.3.4.1 Walker and Rollators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.5. Cranes and Crutches Market
      • 4.3.5.1 Cranes and Crutches Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.6. Door Openers Market
      • 4.3.6.1 Door Openers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.7. Other Devices Market
      • 4.3.7.1 Other Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Bathroom Safety Devices and Medical Furniture
    • 4.4.1. Bathroom Safety Devices and Medical Furniture Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Commodes and Toilets Market
      • 4.4.2.1 Commodes and Toilets Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Mattress & Bedding Devices Market
      • 4.4.3.1 Mattress & Bedding Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Monitoring and Therapeutic Devices
    • 4.5.1. Monitoring and Therapeutic Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Blood Sugar Monitors Market
      • 4.5.2.1 Blood Sugar Monitors Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Continuous Passive Motion (CPM) Market
      • 4.5.3.1 Commodes and Toilets Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.4. Infusion Pumps Market
      • 4.5.4.1 Infusion Pumps Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.5. Nebulizers Market
      • 4.5.5.1 Nebulizers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.6. Infusion Pumps Market
      • 4.5.6.1 Infusion Pumps Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.7. Oxygen Equipment Market
      • 4.5.7.1 Oxygen Equipment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.8. Continuous Positive Airway Pressure (CPAP) Market
      • 4.5.8.1 Continuous Positive Airway Pressure (CPAP) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.9. Suction pumps Market
      • 4.5.9.1 Suction Pumps Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.10. Traction equipment Market
      • 4.5.10.1 Traction Equipment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.11. Others Market
      • 4.5.11.1 Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.11.2 Insulin Pumps Market
        • 4.5.11.2.1 Insulin Pumps Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.11.3 Ostomy Bags & Accessories Market
        • 4.5.11.3.1 Ostomy Bags & Accessories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.11.4 Wound Care Products Market
        • 4.5.11.4.1 Wound Care Products Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.11.5 Cardiology Devices Market
        • 4.5.11.5.1 Cardiology Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.11.6 Vital Signs Monitor Market
        • 4.5.11.6.1 Vital Signs Monitor Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.11.7 Respiratory Supplies Market
        • 4.5.11.7.1 Respiratory Supplies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.11.8 Urinary Supplies Market
        • 4.5.11.8.1 Urinary Supplies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.11.9 Diabetic Supplies Market
        • 4.5.11.9.1 Diabetic Supplies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.11.10 Incontinence Products Market
        • 4.5.11.10.1 Incontinence Products Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.11.11 Orthopedic Braces & Support Market
        • 4.5.11.11.1 Orthopedic Braces & Support Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.11.12 Muscle Stimulators Market
        • 4.5.11.12.1 Muscle Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.11.13 Others Market
        • 4.5.11.13.1 Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. DME Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. DME Market: End Use Movement Analysis & Market Share, 2025 & 2033
  • 5.3. Hospitals
    • 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Specialty Clinics
    • 5.4.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Ambulatory Surgical Centers
    • 5.5.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Diagnostic Centers
    • 5.6.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Home Healthcare
    • 5.7.1. Home Healthcare Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Market Participant Categorization
  • 6.2. Key Company Profiles
    • 6.2.1. Invacare Corporation
      • 6.2.1.1. Company Overview
      • 6.2.1.2. Financial Performance
      • 6.2.1.3. Product Benchmarking
      • 6.2.1.4. Strategic Initiatives
    • 6.2.2. Sunrise Medical
      • 6.2.2.1. Company Overview
      • 6.2.2.2. Financial Performance
      • 6.2.2.3. Product Benchmarking
      • 6.2.2.4. Strategic Initiatives
    • 6.2.3. Arjo
      • 6.2.3.1. Company Overview
      • 6.2.3.2. Financial Performance
      • 6.2.3.3. Product Benchmarking
      • 6.2.3.4. Strategic Initiatives
    • 6.2.4. Medline Industries, Inc.
      • 6.2.4.1. Company Overview
      • 6.2.4.2. Financial Performance
      • 6.2.4.3. Product Benchmarking
      • 6.2.4.4. Strategic Initiatives
    • 6.2.5. GE HealthCare
      • 6.2.5.1. Company Overview
      • 6.2.5.2. Financial Performance
      • 6.2.5.3. Product Benchmarking
      • 6.2.5.4. Strategic Initiatives
    • 6.2.6. GF Healthcare Products, Inc.
      • 6.2.6.1. Company Overview
      • 6.2.6.2. Financial Performance
      • 6.2.6.3. Product Benchmarking
      • 6.2.6.4. Strategic Initiatives
    • 6.2.7. Carex Health Brands, Inc.
      • 6.2.7.1. Company Overview
      • 6.2.7.2. Financial Performance
      • 6.2.7.3. Product Benchmarking
      • 6.2.7.4. Strategic Initiatives
    • 6.2.8. Cardinal Health
      • 6.2.8.1. Company Overview
      • 6.2.8.2. Financial Performance
      • 6.2.8.3. Product Benchmarking
      • 6.2.8.4. Strategic Initiatives
    • 6.2.9. Drive DeVilbiss Healthcare
      • 6.2.9.1. Company Overview
      • 6.2.9.2. Financial Performance
      • 6.2.9.3. Product Benchmarking
      • 6.2.9.4. Strategic Initiatives
    • 6.2.10. NOVA Medical Products
      • 6.2.10.1. Company Overview
      • 6.2.10.2. Financial Performance
      • 6.2.10.3. Product Benchmarking
      • 6.2.10.4. Strategic Initiatives
    • 6.2.11. Kaye Products, Inc.
      • 6.2.11.1. Company Overview
      • 6.2.11.2. Financial Performance
      • 6.2.11.3. Product Benchmarking
      • 6.2.11.4. Strategic Initiatives
    • 6.2.12. Karman Healthcare, Inc.
      • 6.2.12.1. Company Overview
      • 6.2.12.2. Financial Performance
      • 6.2.12.3. Product Benchmarking
      • 6.2.12.4. Strategic Initiatives
    • 6.2.13. Numotion
      • 6.2.13.1. Company Overview
      • 6.2.13.2. Financial Performance
      • 6.2.13.3. Product Benchmarking
      • 6.2.13.4. Strategic Initiatives
    • 6.2.14. Pride Mobility Products Corporation
      • 6.2.14.1. Company Overview
      • 6.2.14.2. Financial Performance
      • 6.2.14.3. Product Benchmarking
      • 6.2.14.4. Strategic Initiatives
    • 6.2.15. Inogen, Inc.
      • 6.2.15.1. Company Overview
      • 6.2.15.2. Financial Performance
      • 6.2.15.3. Product Benchmarking
      • 6.2.15.4. Strategic Initiatives
    • 6.2.16. CAIRE, Inc.
      • 6.2.16.1. Company Overview
      • 6.2.16.2. Financial Performance
      • 6.2.16.3. Product Benchmarking
      • 6.2.16.4. Strategic Initiatives
    • 6.2.17. Portable Oxygen Solutions
      • 6.2.17.1. Company Overview
      • 6.2.17.2. Financial Performance
      • 6.2.17.3. Product Benchmarking
      • 6.2.17.4. Strategic Initiatives
    • 6.2.18. Rhythm Healthcare, LLC
      • 6.2.18.1. Company Overview
      • 6.2.18.2. Financial Performance
      • 6.2.18.3. Product Benchmarking
      • 6.2.18.4. Strategic Initiatives
    • 6.2.19. MedaCure Inc.
      • 6.2.19.1. Company Overview
      • 6.2.19.2. Financial Performance
      • 6.2.19.3. Product Benchmarking
      • 6.2.19.4. Strategic Initiatives
    • 6.2.20. Compass Health Brands
      • 6.2.20.1. Company Overview
      • 6.2.20.2. Financial Performance
      • 6.2.20.3. Product Benchmarking
      • 6.2.20.4. Strategic Initiatives
    • 6.2.21. Thermo Fisher Scientific, Inc.
      • 6.2.21.1. Company Overview
      • 6.2.21.2. Financial Performance
      • 6.2.21.3. Product Benchmarking
      • 6.2.21.4. Strategic Initiatives
    • 6.2.22. Abbott
      • 6.2.22.1. Company Overview
      • 6.2.22.2. Financial Performance
      • 6.2.22.3. Product Benchmarking
      • 6.2.22.4. Strategic Initiatives
    • 6.2.23. F. Hoffmann-La Roche Ltd.
      • 6.2.23.1. Company Overview
      • 6.2.23.2. Financial Performance
      • 6.2.23.3. Product Benchmarking
      • 6.2.23.4. Strategic Initiatives
    • 6.2.24. Medtronic
      • 6.2.24.1. Company Overview
      • 6.2.24.2. Financial Performance
      • 6.2.24.3. Product Benchmarking
      • 6.2.24.4. Strategic Initiatives
    • 6.2.25. Ascensia Diabetes Care Holdings AG
      • 6.2.25.1. Company Overview
      • 6.2.25.2. Financial Performance
      • 6.2.25.3. Product Benchmarking
      • 6.2.25.4. Strategic Initiatives
    • 6.2.26. Byram Healthcare Centers, Inc.
      • 6.2.26.1. Company Overview
      • 6.2.26.2. Financial Performance
      • 6.2.26.3. Product Benchmarking
      • 6.2.26.4. Strategic Initiatives
    • 6.2.27. Novo Nordisk
      • 6.2.27.1. Company Overview
      • 6.2.27.2. Financial Performance
      • 6.2.27.3. Product Benchmarking
      • 6.2.27.4. Strategic Initiatives
    • 6.2.28. Insulet Corporation
      • 6.2.28.1. Company Overview
      • 6.2.28.2. Financial Performance
      • 6.2.28.3. Product Benchmarking
      • 6.2.28.4. Strategic Initiatives
    • 6.2.29. Baxter
      • 6.2.29.1. Company Overview
      • 6.2.29.2. Financial Performance
      • 6.2.29.3. Product Benchmarking
      • 6.2.29.4. Strategic Initiatives
    • 6.2.30. B. Braun SE
      • 6.2.30.1. Company Overview
      • 6.2.30.2. Financial Performance
      • 6.2.30.3. Product Benchmarking
      • 6.2.30.4. Strategic Initiatives
    • 6.2.31. Micrel Medical Devices SA
      • 6.2.31.1. Company Overview
      • 6.2.31.2. Financial Performance
      • 6.2.31.3. Product Benchmarking
      • 6.2.31.4. Strategic Initiatives
    • 6.2.32. Boston Scientific Corporation
      • 6.2.32.1. Company Overview
      • 6.2.32.2. Financial Performance
      • 6.2.32.3. Product Benchmarking
      • 6.2.32.4. Strategic Initiatives
    • 6.2.33. Tandem Diabetes Care, Inc.
      • 6.2.33.1. Company Overview
      • 6.2.33.2. Financial Performance
      • 6.2.33.3. Product Benchmarking
      • 6.2.33.4. Strategic Initiatives
    • 6.2.34. BD
      • 6.2.34.1. Company Overview
      • 6.2.34.2. Financial Performance
      • 6.2.34.3. Product Benchmarking
      • 6.2.34.4. Strategic Initiatives
    • 6.2.35. Moog, Inc.
      • 6.2.35.1. Company Overview
      • 6.2.35.2. Financial Performance
      • 6.2.35.3. Product Benchmarking
      • 6.2.35.4. Strategic Initiatives
    • 6.2.36. IRadimed Corporation
      • 6.2.36.1. Company Overview
      • 6.2.36.2. Financial Performance
      • 6.2.36.3. Product Benchmarking
      • 6.2.36.4. Strategic Initiatives
    • 6.2.37. Koninklijke Philips N.V.
      • 6.2.37.1. Company Overview
      • 6.2.37.2. Financial Performance
      • 6.2.37.3. Product Benchmarking
      • 6.2.37.4. Strategic Initiatives
    • 6.2.38. Siemens Medical Solutions USA, Inc.
      • 6.2.38.1. Company Overview
      • 6.2.38.2. Financial Performance
      • 6.2.38.3. Product Benchmarking
      • 6.2.38.4. Strategic Initiatives
    • 6.2.39. Essity
      • 6.2.39.1. Company Overview
      • 6.2.39.2. Financial Performance
      • 6.2.39.3. Product Benchmarking
      • 6.2.39.4. Strategic Initiatives
    • 6.2.40. Coloplast Corporation
      • 6.2.40.1. Company Overview
      • 6.2.40.2. Financial Performance
      • 6.2.40.3. Product Benchmarking
      • 6.2.40.4. Strategic Initiatives
    • 6.2.41. Paul Hartmann AG
      • 6.2.41.1. Company Overview
      • 6.2.41.2. Financial Performance
      • 6.2.41.3. Product Benchmarking
      • 6.2.41.4. Strategic Initiatives
    • 6.2.42. Hollister Incorporated
      • 6.2.42.1. Company Overview
      • 6.2.42.2. Financial Performance
      • 6.2.42.3. Product Benchmarking
      • 6.2.42.4. Strategic Initiatives
    • 6.2.43. Convatec Group PLC
      • 6.2.43.1. Company Overview
      • 6.2.43.2. Financial Performance
      • 6.2.43.3. Product Benchmarking
      • 6.2.43.4. Strategic Initiatives
    • 6.2.44. Enovis Corporation
      • 6.2.44.1. Company Overview
      • 6.2.44.2. Financial Performance
      • 6.2.44.3. Product Benchmarking
      • 6.2.44.4. Strategic Initiatives
    • 6.2.45. Zynex, Inc.
      • 6.2.45.1. Company Overview
      • 6.2.45.2. Financial Performance
      • 6.2.45.3. Product Benchmarking
      • 6.2.45.4. Strategic Initiatives
    • 6.2.46. ZOLL Medical Corporation
      • 6.2.46.1. Company Overview
      • 6.2.46.2. Financial Performance
      • 6.2.46.3. Product Benchmarking
      • 6.2.46.4. Strategic Initiatives
    • 6.2.47. Ossur
      • 6.2.47.1. Company Overview
      • 6.2.47.2. Financial Performance
      • 6.2.47.3. Product Benchmarking
      • 6.2.47.4. Strategic Initiatives
    • 6.2.48. Breg, Inc.
      • 6.2.48.1. Company Overview
      • 6.2.48.2. Financial Performance
      • 6.2.48.3. Product Benchmarking
      • 6.2.48.4. Strategic Initiatives
    • 6.2.49. Bauerfeind USA, Inc.
      • 6.2.49.1. Company Overview
      • 6.2.49.2. Financial Performance
      • 6.2.49.3. Product Benchmarking
      • 6.2.49.4. Strategic Initiatives
    • 6.2.50. Biotronik
      • 6.2.50.1. Company Overview
      • 6.2.50.2. Financial Performance
      • 6.2.50.3. Product Benchmarking
      • 6.2.50.4. Strategic Initiatives
    • 6.2.51. AliMed
      • 6.2.51.1. Heat Company Overview
      • 6.2.51.2. Financial Performance
      • 6.2.51.3. Product Benchmarking
      • 6.2.51.4. Strategic Initiatives
  • 6.3. Map Analysis/ Company Market Position Analysis
  • 6.4. Estimated Company Market Share Analysis, 2025
  • 6.5. List of Other Key Market Players

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 US DME Market, by Product, 2021 - 2033 (USD Million)
  • Table 4 US DME Market, by End Use, 2021 - 2033 (USD Million)
  • Table 5 Participant's Overview
  • Table 6 Financial Performance
  • Table 7 Service Benchmarking
  • Table 8 Strategic Initiatives

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 DME Market, Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 10 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 Country Marketplace: Key Takeaways
  • Fig. 13 U.S. DME Market, 2021 - 2033 (USD Million)